Company Profile for Diosynth Biotechnology.Diosynth Biotechnology, a unit of Akzo Nobel Akzo Nobel is a multinational company, active in the fields of healthcare products, coatings and chemicals. Headquartered in Amsterdam, the Netherlands, the company has activities in more than 80 countries, and employs approximately 62,000 people. , with an 80-year heritage in biologics manufacturing is a full service contract biopharmaceutical manufacturer serving the pharmaceutical and biotechnology industries. As a market-driven and technology-based organization, Diosynth Biotechnology is a leader in process development and cGMP manufacturing of recombinant proteins Since human recombinants have replaced the animal version in human therapeutics, the prefix of "rh" for "human recombinant" appears less and less in the literature Human recombinants that replaced animal or harvested from human types abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. and EMEA (Europe, Middle East, Africa) Refers to that region of the world. For example, one might see products packaged differently for the UK, EMEA and Asia Pacific markets. inspected facilities located in the USA and The Netherlands. Our goal is to increase the value of our customers' pipeline and products. We help our customers succeed by driving products efficiently, rapidly and cost-effectively from pre-clinical development Pre-clinical development is a stage in the development of a new drug that begins before clinical trials (testing in humans) can begin, and during which important safety and pharmacology data is collected. to market supply. Our expertise in the development, refinement and technology transfer of pre-clinical through commercial cGMP manufacturing processes has been repeatedly demonstrated and our scale-up, validation and regulatory services serve and support customers from across North America North America, third largest continent (1990 est. pop. 365,000,000), c.9,400,000 sq mi (24,346,000 sq km), the northern of the two continents of the Western Hemisphere. , Europe and Japan.
Company: Diosynth Biotechnology
Headquarters Address: 101 J Morris Commons Lane
Morrisville, NC 27560
Main Telephone: 919-337-4477
Website: www.diosynthbiotechnology.com
Type of Organization: Private
Industry: Health: Biotechnology
Key Executives: President & CEO: Frank Tielens
Vice President, Marketing & Sales:
Richard Basile
Vice President, Global Operations:
Chris van Eekelen
Marketing & Business Development
Contact: Magnus Persmark
Phone: 919-337-4440
Email: magnus.persmark@diosynth-rtp.com
Marketing & Sales, Europe
Contact: Erik van den Berg
Phone: 31-412-662468
Email: erik.vandenberg@diosynth.com
Commercial Development, U.S.
Contact: Karen O'Malley
Phone: 919-337-4242
Email: karen.omalley@diosynth-rtp.com
|
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion